Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Molecular Characteristics of Non-Small Cell Lung Cancer

  • Read more about Molecular Characteristics of Non-Small Cell Lung Cancer
US Application 60/312,400
Filed on 2001-08-16

Methods, Compositions and Systems for the Identification and Characterization of Cytochrome bc1 Inhibitors

  • Read more about Methods, Compositions and Systems for the Identification and Characterization of Cytochrome bc1 Inhibitors
US Application 60/404,146
Filed on 2002-08-19

Nucleic Acids of the Human ABCA5, ABCA6, ABCA9 and ABCA10 Genes, Vectors Containing Such Nucleic Acids and Uses Thereof

  • Read more about Nucleic Acids of the Human ABCA5, ABCA6, ABCA9 and ABCA10 Genes, Vectors Containing Such Nucleic Acids and Uses Thereof
US Application 60/263,231
Filed on 2001-01-23

Vasoregulating Compounds and Methods of Their Use

  • Read more about Vasoregulating Compounds and Methods of Their Use
US Application 60/416,291
Filed on 2002-10-04

Universal Detector and Adaptor for Microelectric Nanochip SNP Detection

  • Read more about Universal Detector and Adaptor for Microelectric Nanochip SNP Detection
US Application 60/404,777
Filed on 2002-08-21

Structure of famoxadone in complex with cytochrome bc1 complex

  • Read more about Structure of famoxadone in complex with cytochrome bc1 complex
US Application 60/401,039
Filed on 2002-08-06

Immunotherapy With in Vitro Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy

  • Read more about Immunotherapy With in Vitro Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
US Application 60/408,681
Filed on 2002-09-06

AMIDE-BEARING BENZOLACTAMS THAT MODULATE PROTEIN KINASE C, AND METHOD OF USE THEREOF

  • Read more about AMIDE-BEARING BENZOLACTAMS THAT MODULATE PROTEIN KINASE C, AND METHOD OF USE THEREOF
US Application 60/395,914
Filed on 2002-07-15

Persistent HIV-1 Infection of Natural Killer Cells In Patients Receiving Highly Active Antiretroviral Therapy

  • Read more about Persistent HIV-1 Infection of Natural Killer Cells In Patients Receiving Highly Active Antiretroviral Therapy
US Application 60/395,166
Filed on 2002-07-10

AKT INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

  • Read more about AKT INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
US Application 60/407,239
Filed on 2002-09-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 180
  • Page 181
  • Page 182
  • Page 183
  • Page 184
  • Page 185
  • Page 186
  • Page 187
  • Page 188
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health